Trials / Conditions / PPHN
PPHN
6 registered clinical trials studyying PPHN.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn NCT06860399 | Damascus University | Phase 1 / Phase 2 |
| Active Not Recruiting | the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) NCT05527704 | Medical University of Warsaw | Phase 3 |
| Withdrawn | Predictors of Inhaled Nitric Oxide Responsiveness in Patients With PPHN NCT06043635 | Nationwide Children's Hospital | — |
| Withdrawn | Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates NCT03499418 | Princess Anna Mazowiecka Hospital, Warsaw, Poland | — |
| Completed | Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn NCT04328636 | Sohag University | Phase 1 / Phase 2 |
| Terminated | Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension NCT01069861 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 2 |